Trellus Health PLC
TRLS
Company Profile
Business description
Trellus Health PLC is commercializing the provision of digital chronic condition management solutions for employers and health plans that utilize the scientifically validated GRITT resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate to coordinate and deliver personalized care. The company is initially focused on Inflammatory Bowel Diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis but considers its approach to have potential utility and demand across many chronic conditions.
Contact
19 Stanwell Road
Avon House, Penarth
CardiffCF64 2EZ
GBRSector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 December 2025
Employees
18
Stocks News & Analysis
stocks
Fair value downgraded for ASX heavyweight
Our capital allocation rating was also lowered due to balance sheet weakness.
stocks
ChatGPT enters the retail space and one company surges
Investors cheer the ability to purchase directly from ChatGPT.
stocks
Alibaba fair value increases by 49%
Stronger-than-expected AI demand internationally and domestically.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,136.60 | 15.10 | 0.17% |
CAC 40 | 7,966.95 | 71.01 | 0.90% |
DAX 40 | 24,113.62 | 232.90 | 0.98% |
Dow JONES (US) | 46,375.36 | 22.53 | -0.05% |
FTSE 100 | 9,446.43 | 96.00 | 1.03% |
HKSE | 26,855.56 | 232.68 | 0.87% |
NASDAQ | 22,694.54 | 34.53 | 0.15% |
Nikkei 225 | 44,550.85 | 381.78 | -0.85% |
NZX 50 Index | 13,433.99 | 141.63 | 1.07% |
S&P 500 | 6,692.03 | 3.57 | 0.05% |
S&P/ASX 200 | 8,845.70 | 12.30 | 0.14% |
SSE Composite Index | 3,882.78 | 20.25 | 0.52% |